TP53 and metabolic dysfunction-associated steatotic liver disease: Recently, the miR-34a/SIRT1/p53 signaling pathway was reported to be involved in human NASH and positively related to NAFLD severity, which is the result of a link between hepatocyte apoptosis and the miR-34a/SIRT1/p53 signaling pathway [16].